Bulletin of Experimental Biology and Medicine

, Volume 147, Issue 2, pp 220–225 | Cite as

Hepatitis B Virus Genetic Typing Using Mass-Spectrometry

  • M. V. Malakhova
  • E. N. Ilina
  • V. M. Govorun
  • S. A. Shutko
  • K. R. Dudina
  • O. O. Znoyko
  • E. A. Klimova
  • N. D. Iushchuk
Virology
First Online:
Received:

Mini-sequencing with subsequent result registration using MALDI-ToF mass-spectrometry was employed for hepatitis B virus genetic typing in Russian population. This approach was employed for hepatitis B virus genetic typing in HBsAg-positive patients with chronic hepatitis B, hepatitis of combined etiology and hepatic cirrhosis and allowed to show the prevalence of D genotype (83.3%) in all groups of patients. Other hepatitis B virus genotypes: genotype A (5.9%), genotype C (3.6%), and mixed infection with D and C (7.2%) were also found in patients with chronic hepatitis B and hepatic cirrhosis. All genotypes were found in patients with chronic hepatitis B and hepatic cirrhosis. Chronic hepatitis of combined etiology was noted only in patients with genotype D. Possibility of detection of mixed infection with hepatitis B viruses of various genotypes is a distinct advantage of mini-sequencing approach over direct nucleotide sequence evaluation for hepatitis B virus genetic typing.

Key Words

viral hepatitis B genetic typing mini-sequencing mass-spectrometry 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E. N. Ilina, M. V. Malakhova, E. V. Generozov, et al., Biomed. Chim., 51, No. 1, 41-47 (2005).Google Scholar
  2. 2.
    P. Araus-Ruiz, H. Norder, K. A. Visona, and L. O. Magnius, J. Med. Virol., 51, No. 4, 305-312 (1997).CrossRefGoogle Scholar
  3. 3.
    H. L. Chan, M. Hussain, and A. S. Loc, Hepatology, 29, No. 3, 976-984 (1999).PubMedCrossRefGoogle Scholar
  4. 4.
    G. Francois, M. Kew, P. Van Damme, et al., Vaccine, 19, No. 28-29, 3799-3815 (2001).PubMedCrossRefGoogle Scholar
  5. 5.
    D. Holmes and M. Quigley, Anal. Biochem., 114, No. 1, 193-197 (1981).PubMedCrossRefGoogle Scholar
  6. 6.
    H. L. Janssen, M. van Zonneveld, H. Senturk, et al., Lancet., 365, 123-129 (2005).PubMedCrossRefGoogle Scholar
  7. 7.
    J. H. Kao, P. J. Chen, M. Y. Lai, and D. S. Chen, Gastroenterology, 118, No. 3, 554-559 (2000).PubMedCrossRefGoogle Scholar
  8. 8.
    M. Lindh, J. E. Gonzalez, G. Norkrans, and P. Horal, J. Virol. Method., 72, No. 2, 163-174 (1998).CrossRefGoogle Scholar
  9. 9.
    C. M. Lo, C. K. Cheung, G. K. Lau, et al., Am. J. Transplant., 5, No. 8, 1893-1900 (2005).PubMedCrossRefGoogle Scholar
  10. 10.
    V. M. Morozov, M. M. Pisareva, and M. P. Groudinin, Gene, 260, Nos. 1-2, 55-65 (2000).PubMedCrossRefGoogle Scholar
  11. 11.
    J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular cloning: a laboratory manual, N. Y. (1989).Google Scholar
  12. 12.
    J. M. Sanchez-Tapias, J. Costa, A. Mas, et al., Gastroenterology, 123, No. 6, 1848-1856 (2002).PubMedCrossRefGoogle Scholar
  13. 13.
    L. Stuyver, S. De Gendt, C. Van Geyt, et al., J. Gen. Virol., 81, Pt. 1, 67-74 (2000).PubMedGoogle Scholar
  14. 14.
    S. Payungporn, P. Tangkijvanich, P. Jantaradsamee, et al., J. Virol. Methods, 120, No. 2, 131-140 (2004).PubMedCrossRefGoogle Scholar
  15. 15.
    Y. Song, E. Dai, J. Wang, et al., Mol. Cell. Probes, 20, No. 2, 121-127 (2006).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2009

Authors and Affiliations

  • M. V. Malakhova
    • 1
  • E. N. Ilina
    • 1
  • V. M. Govorun
    • 1
  • S. A. Shutko
    • 2
  • K. R. Dudina
    • 2
  • O. O. Znoyko
    • 2
  • E. A. Klimova
    • 2
  • N. D. Iushchuk
    • 2
  1. 1.Scientific Research Institute of Physical-Chemical MedicineMoscowRussia
  2. 2.Moscow State Medical-Stomatological UniversityMoscowRussia

Personalised recommendations